Use of rituximab in idiopathic retroperitoneal fibrosis
Abstract Background Retroperitoneal fibrosis (RPF) is characterized by the proliferation of fibrous tissue in the retroperitoneum. The majority of RPF cases are due to idiopathic or IgG4-related disease. Recent studies on IgG4-related disease have shown rituximab to be an effective treatment. The cu...
Main Authors: | Veronika Boyeva, Hatim Alabsi, Michael A. Seidman, Ryan Paterson, Jason Kur, Luke Y. C. Chen, Silvia D. Chang, Mollie Carruthers |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | BMC Rheumatology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41927-020-00140-9 |
Similar Items
-
Ergotamine Induced Retroperitoneal Fibrosis
by: Susama Patra, et al.
Published: (2021-01-01) -
Use of resuscitation promoting factors to screen for tuberculosis infection in household-exposed children in The Gambia
by: W. van Loon, et al.
Published: (2020-07-01) -
RpfC regulates the expression of the key regulator hrpX of the hrp/T3SS system in Xanthomonas campestris pv. campestris
by: Bo-Le Jiang, et al.
Published: (2018-09-01) -
"When the RP gets in the way of the F": Star Image and intertextuality in real person(a) fiction
by: Milena Popova
Published: (2017-09-01) -
Unseen international music idol femslash
by: Elaine Han Lin
Published: (2017-06-01)